AKBA Akebia Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 5, 2026
$0,87
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,81minimo 52 sett.
$3,20massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Ricavi (TTM)
$219M
i tuoi badge
Intervallo 52 sett.
$1–$3
Rating Analisti
BUY
Prezzo Obiettivo
$4
P/E
-7.9
ROE
-109.4%
Margine di Profitto Netto
-13.5%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
AKBA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.86
Capitalizzazione di Mercato (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Ricavi (TTM)
$219M
ROE (TTM)
-109.4%
D/E Debito/Patrimonio (MRQ)
2.0
Intervallo 52 sett.
$1–$3
AKBA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$236M2020-12-31 → 2025-12-31
EPS$-0.022020-12-31 → 2025-12-31
Flusso di cassa libero$68M2020-12-31 → 2025-12-31
Margine netto-13.5%2020-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | AKBA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -7.9media 5 anni ≈-22.9 | ≈-22.9 | · | · | |
| P/S (TTM) | 1.1media 5 anni ≈1.9 | ≈1.9 | 26.3 | Sottovalutato | |
| P/B (MRQ) | 9.4media 5 anni ≈-1.2 | ≈-1.2 | 2.9 | Sopravvalutato | |
| EV / EBITDA | 4.0media 5 anni ≈-0.3 | ≈-0.3 | · | · | |
| Prezzo / FCF (TTM) | 5.8media 5 anni ≈-4.8 | ≈-4.8 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 5.7media 5 anni ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue (EV / Ricavi) | 0.4media 5 anni ≈1.7 | ≈1.7 | · | · | |
| EV / FCF | 1.4media 5 anni ≈-5.3 | ≈-5.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | AKBA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -6.9%media 5 anni ≈-18.2% | ≈-18.2% | -472.2% | Di prim'ordine | |
| EBITDA Margin (Margine EBITDA) | 10.0%media 5 anni ≈-18.1% | ≈-18.1% | -469.9% | Di prim'ordine | |
| Margine ante imposte (TTM) | -12.7%media 5 anni ≈-26.0% | ≈-26.0% | -115.1% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | -13.5%media 5 anni ≈-26.1% | ≈-26.1% | -420.3% | Di prim'ordine | |
| ROA (TTM) | -8.5%media 5 anni ≈-17.2% | ≈-17.2% | -28.8% | Di prim'ordine | |
| ROE (TTM) | -109.4%media 5 anni ≈90.2% | ≈90.2% | -36.9% | Di prim'ordine | |
| ROIC | 41.7% | · | 0.40% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | AKBA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 2.0media 5 anni ≈-0.1 | ≈-0.1 | · | · | |
| Rapporto corrente (MRQ) | 1.4media 5 anni ≈1.4 | ≈1.4 | 5.9 | Bassa liquidità | |
| Quick Ratio | 1.4media 5 anni ≈1.1 | ≈1.1 | 5.5 | Bassa liquidità | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 1.0media 5 anni ≈0.0 | ≈0.0 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | AKBA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 47.5%media 5 anni ≈8.6% | ≈8.6% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -6.9%media 5 anni ≈-9.6% | ≈-9.6% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -4.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | AKBA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.8media 5 anni ≈0.7 | ≈0.7 | 0.2 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 2.5media 5 anni ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Rotazione dei crediti) | 5.8media 5 anni ≈5.6 | ≈5.6 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.2M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
49.6%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 5, 2026 | $-0.03 | $-0.04 | 33.2% |
| 31 Marzo 2026 | Mag 11, 2026 | $-0.03 | $-0.03 | -4.9% |
| 31 Dicembre 2025 | $-0.05 | $-0.03 | -96.1% | |
| 30 Settembre 2025 | $0.00 | $-0.02 | 100.0% | |
| 30 Giugno 2025 | $0.00 | $-0.02 | 100.0% | |
| 31 Marzo 2025 | $0.03 | $-0.05 | 165.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $-0.22 | $-0.16 | · | $0.43 | $1.67 | $3.24 | $5.44 | $2.51 | $1.76 | $4.27 | $5.11 | |
| Revenue / Share | $0.92 | $0.76 | $1.04 | $1.60 | $1.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.26 | $-0.19 | $-0.12 | $-0.40 | $-1.52 | · | · | · | · | · | · | · | |
| Cash / Share | $0.70 | $0.23 | $0.22 | · | $0.85 | $1.54 | $1.21 | $0.90 | $1.47 | $4.85 | $1.62 | $1.61 | |
| EPS (TTM) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | $-1.86 | $-1.86 | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | · | 264,786,432 | 262,565,500 | 235,497,720 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | · | 274,372,722 | 271,104,020 | 241,602,853 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.10 | · | $0.16 | $0.11 | $0.09 | · | $-0.24 | $-0.16 | $-0.13 | · | $-0.21 | $-0.14 | $-0.08 | · | $0.08 | |
| Revenue / Share | $0.18 | $0.20 | · | $0.21 | $0.23 | $0.24 | · | $0.18 | $0.21 | $0.16 | · | $0.22 | $0.30 | $0.22 | · | $0.27 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.57 | $0.61 | · | $0.63 | $0.52 | $0.43 | · | $0.16 | $0.19 | $0.20 | · | $0.25 | $0.28 | $0.31 | · | $0.79 | |
| EPS (TTM) | $-0.11 | $-0.08 | · | $-0.07 | $-0.17 | $-0.21 | · | $-0.22 | $-0.20 | $-0.22 | · | $-0.32 | $-0.53 | $-0.32 | · | $-0.89 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $232M | · | $225M | $204M | $185M | · | $170M | $174M | $187M | · | $194M | $201M | $271M | · | $294M | |
| Net Income TTM | $-30M | $-21M | · | $-16M | $-36M | $-45M | · | $-46M | $-40M | $-43M | · | $-59M | $-98M | $-58M | · | $-158M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -10.4 | -17.4 | · | -39.0 | -21.4 | -9.1 | · | -6.0 | -5.1 | -8.3 | · | -3.6 | -1.7 | -1.8 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.2 | 4.7 | 2.7 | · | 1.6 | 1.2 | 2.0 | · | 1.1 | 0.9 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.7 | 4.3 | 2.4 | · | 1.7 | 1.2 | 2.0 | · | 1.1 | 0.8 | 0.4 | · | -0.1 | |
| Earnings Yield | -9.7% | -5.8% | · | -2.6% | -4.7% | -10.9% | · | -16.7% | -19.6% | -12.0% | · | -28.1% | -57.9% | -57.1% | · | -281.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Ricavi | $236M | $160M | $195M | · | $292M |
| Margine Operativo % | 10.0% | -31.5% | -23.8% | · | -27.6% |
| Utile netto | $-5M | $-69M | $-52M | · | $-94M |
| EPS Diluito | $-0.02 | $-0.33 | $-0.28 | · | $-0.52 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 1.5 | -0.8 | -1.1 | · | · |
| Rapporto corrente | 1.6 | 1.4 | 1.2 | · | · |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $68M | $-41M | $-23M | · | $-73M |
Proprietari istituzionali (13F) 180 filer · $144.4M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
180
Valore detenuto
$144.4M
Nuove posizioni
39
Posizioni chiuse
35
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 39 (+4 vs trimestre precedente) | 35 (+8 vs trimestre precedente) | 68 (+25 vs trimestre precedente) | 34 (-20 vs trimestre precedente) | +6.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $25.786.481 | 16.016.448 | 17,86% | Azioni |
| BlackRock, Inc. | $22.784.466 | 19.986.374 | 15,78% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.907.243 | 11.322.143 | 8,94% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $10.432.737 | 9.151.524 | 7,23% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $7.671.148 | 6.727.302 | 5,31% | Azioni |
| STATE STREET CORP | $6.145.572 | 5.390.853 | 4,26% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.871.250 | 4.273.026 | 3,37% | Azioni |
| GOLDMAN SACHS GROUP INC | $4.205.650 | 3.689.167 | 2,91% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $3.644.130 | 3.196.605 | 2,52% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.888.734 | 2.533.977 | 2,00% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $2.777.807 | 2.436.673 | 1,92% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.622.499 | 2.300.438 | 1,82% | Azioni |
| NORTHERN TRUST CORP | $2.462.816 | 2.160.365 | 1,71% | Azioni |
| Nantahala Capital Management, LLC | $2.280.000 | 2.000.000 | 1,58% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.176.029 | 1.908.797 | 1,51% | Azioni |
| FMR LLC | $2.133.008 | 1.871.059 | 1,48% | Azioni |
| Qube Research & Technologies Ltd | $2.028.866 | 1.779.707 | 1,41% | Azioni |
| CITADEL ADVISORS LLC | $1.958.131 | 1.717.659 | 1,36% | Azioni |
| UBS Group AG | $1.567.442 | 1.374.950 | 1,09% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.395.318 | 1.223.963 | 0,97% | Azioni |
| CITIGROUP INC | $1.282.010 | 1.124.570 | 0,89% | Azioni |
| MORGAN STANLEY | $799.756 | 701.540 | 0,55% | Azioni |
| Invesco Ltd. | $792.218 | 694.928 | 0,55% | Azioni |
| MANGROVE PARTNERS IM, LLC | $760.328 | 666.954 | 0,53% | Azioni |
| AMERIPRISE FINANCIAL INC | $713.823 | 626.160 | 0,49% | Azioni |
| Bank of New York Mellon Corp | $705.830 | 619.149 | 0,49% | Azioni |
| Nuveen, LLC | $680.123 | 596.599 | 0,47% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672.396 | 589.821 | 0,47% | Azioni |
| TWO SIGMA ADVISERS, LP | $643.918 | 399.949 | 0,45% | Azioni |
| CHOREO, LLC | $641.162 | 562.423 | 0,44% | Azioni |
| Quantinno Capital Management LP | $640.820 | 562.123 | 0,44% | Azioni |
| Creative Planning | $622.144 | 545.740 | 0,43% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606.265 | 531.813 | 0,42% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $531.832 | 466.519 | 0,37% | Azioni |
| BANK OF AMERICA CORP /DE/ | $522.976 | 458.750 | 0,36% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $493.325 | 354.910 | 0,34% | Azioni |
| Eversept Partners, LP | $486.888 | 427.095 | 0,34% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $408.376 | 358.627 | 0,28% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $368.904 | 323.600 | 0,26% | Azioni |
| VIRTUS ADVISERS, LLC | $359.940 | 315.737 | 0,25% | Azioni |
| RHUMBLINE ADVISERS | $350.544 | 307.503 | 0,24% | Azioni |
| Russell Investments Group, Ltd. | $342.416 | 300.367 | 0,24% | Azioni |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336.186 | 294.900 | 0,23% | Azioni |
| ALPS ADVISORS INC | $310.379 | 272.262 | 0,21% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304.722 | 267.300 | 0,21% | Opzione Put |
| JPMORGAN CHASE & CO | $298.634 | 269.040 | 0,21% | Azioni |
| DEUTSCHE BANK AG\ | $292.847 | 256.883 | 0,20% | Azioni |
| FRANKLIN RESOURCES INC | $286.156 | 251.014 | 0,20% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279.072 | 244.800 | 0,19% | Opzione Call |
| WELLS FARGO & COMPANY/MN | $270.084 | 236.916 | 0,19% | Azioni |
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 depositi | 11 Gennaio 2019 | · | Deposito iniziale | M&A / vendita | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 depositi | 21 Dicembre 2018 | · | Deposito iniziale | Investimento passivo | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 depositi | 10 Agosto 2017 | · | Deposito iniziale | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 depositi | 20 Gennaio 2016 | · | Deposito iniziale | · | SEC |
| Novo A/S ×3 depositi | 18 Novembre 2015 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 38 insider · 17 dirigenti · 20 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John P. Butler | CEO and President | 06 Agosto 2026 M | 3.718.564 | 1 | 4 | $-387.825 |
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 29 Giugno 2026 S | 616.616 | 0 | 2 | $-110.763 |
| Ellen Snow | SVP, CFO and Treasurer | 31 Gennaio 2024 A | 519.300 | 0 | 0 | $0 |
| David A Spellman | SVP, CFO and Treasurer | 16 Maggio 2023 S | 446.483 | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 28 Febbraio 2020 A | 144.642 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Operating Officer | 13 Maggio 2024 S | 672.092 | 0 | 0 | $0 |
| Carolyn M. Rucci | SVP, Chief Legal Officer | 02 Febbraio 2026 S | 588.378 | 0 | 3 | $-96.983 |
| Richard C Malabre | SVP, Chief Accounting Officer | 02 Febbraio 2026 S | 299.390 | 0 | 2 | $-68.838 |
| Nicholas Grund | Chief Commercial Officer | 02 Febbraio 2026 S | 561.750 | 0 | 2 | $-117.912 |
| Steven Keith Burke | SVP, Chief Medical Officer | 02 Febbraio 2026 S | 948.432 | 0 | 3 | $-94.044 |
| Nicole R. Hadas | SVP, Chief Legal Officer | 13 Maggio 2024 S | 651.243 | 0 | 0 | $0 |
| Violetta Cotreau | SVP, Chief Accounting Officer | 12 Maggio 2022 A | 219.954 | 0 | 0 | $0 |
| Dell Faulkingham | SVP, CCO | 28 Febbraio 2022 A | 173.841 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 28 Febbraio 2020 A | 84.679 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 11 Aprile 2019 D | 96.332 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 21 Febbraio 2017 A | 64.585 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 14 Maggio 2014 A | 264.556 | 0 | 0 | $0 |
| Ron Frieson | Direttore | 17 Giugno 2026 A | 165.200 | 0 | 0 | $0 |
| Myles Wolf | Direttore | 17 Giugno 2026 A | 169.081 | 0 | 0 | $0 |
| Cynthia Smith | Direttore | 17 Giugno 2026 A | 196.633 | 0 | 0 | $0 |
| Adrian Adams | Direttore | 17 Giugno 2026 A | 236.200 | 0 | 0 | $0 |
| Michael W Rogers | Direttore | 17 Giugno 2026 A | 197.429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Direttore | 17 Giugno 2026 A | 145.100 | 0 | 0 | $0 |
| Philip J. Vickers | Direttore | 01 Aprile 2026 A | · | 0 | 0 | $0 |
| Steven C Gilman | Direttore | 10 Giugno 2025 A | 152.830 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direttore | 02 Giugno 2021 A | 48.586 | 0 | 0 | $0 |
| Mark J Enyedy | Direttore | 05 Giugno 2020 A | 31.143 | 0 | 0 | $0 |
| Maxine Gowen | Direttore | 05 Giugno 2020 A | 24.133 | 0 | 0 | $0 |
| Jodie Pope Morrison | Direttore | 06 Giugno 2019 A | 58.619 | 0 | 0 | $0 |
| Scott A Canute | Direttore | 06 Giugno 2019 A | 13.700 | 0 | 0 | $0 |
| Michael D. Clayman | Direttore | 14 Giugno 2018 A | · | 0 | 0 | $0 |
| Duane Nash | Direttore | 14 Giugno 2018 A | 21.499 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direttore | 14 Giugno 2018 A | 5.000 | 0 | 0 | $0 |
| Satter Muneer A | Direttore | 14 Giugno 2018 A | 3.037.042 | 0 | 0 | $0 |
| Michael S Wyzga | Direttore | 14 Giugno 2018 A | 1.500 | 0 | 0 | $0 |
| Anupam Dalal | Direttore | 16 Giugno 2016 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | · | 25 Marzo 2014 C | 1.516.387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | · | 25 Marzo 2014 C | 3.405.764 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 17 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 130.501 SH | 02 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,06% | 873.651 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 249.458 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 442.063 SH | 02 Ottobre 2026 | Giornaliero |
| IWO · iShares Trust | 0,01% | 2.169.896 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 123.445 NS | 31 Luglio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.485.665 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,01% | 6.668.524 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 364.328 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 46.198 SH | 03 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 3.164.884 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7.912.283 SH | 19 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24.210 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.230 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 754.414 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 338.893 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 623.464 SH | 11 Settembre 2026 | Giornaliero |
AKBA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 11 analisti
COMPRA
Target mediano
$4.00
+362,4%
4 36,4%
Acquisto forte
5 45,5%
Compra
2 18,2%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
6 analisti · 2026-10-03Target medio $3.92 +352,8%
← Sotto tutti i target
Prezzo attuale $0.86
Basso$1.00
Media$3.92
Alto$6.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 5, 2026